Pamrevlumab (FG-3019), an Anti-Connective Tissue Growth Factor Therapy for Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Trial
2020 ◽
Vol 8
(1)
◽
pp. 25-33
◽
Keyword(s):
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2005 ◽
Vol 171
(9)
◽
pp. 1040-1047
◽
Keyword(s):
2016 ◽
Vol 47
(5)
◽
pp. 1481-1491
◽
2011 ◽
Vol 412
(23-24)
◽
pp. 2211-2215
◽
2004 ◽
Vol 126
(4)
◽
pp. 773S
◽
1999 ◽
Vol 21
(6)
◽
pp. 693-700
◽
2020 ◽
Vol 201
(9)
◽
pp. 1110-1119
◽
Keyword(s):